Dual-acting injectable that targets GLP-1 and GIP receptors for enhanced appetite regulation and blood sugar control. Shown to support significant weight loss in clinical trials.
- Weightloss injection containing tirzepatide
- Mimics GLP1 and GIP to suppress appetite and slow stomach emptying
- Nutrition and medical support provided every step of the way
- Mounjaro 2.5mg – 15mg injection pens